Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : GZSP, Genzyme Surgical Products -- Ignore unavailable to you. Want to Upgrade?

To: peter michaelson who wrote (27)	7/16/1999 2:50:00 PM
From: jeffbas	Read Replies (1) \| Respond to of 55

Peter, I am not a good seller as I have noted. That said, the net cash per share is worth $9. The businesses are worth $7 in my opinion. They are losing a couple of bucks per share per year primarily because of R&D. I think a reasonable expectation is that it reaches a price between net cash per share and that plus 1/2 business value -- or $9-12. That will require breaking out over the first trading day's high and then running more, which will take a while, in my opinion. I think your sale at 6 7/8 of 50% and holding the rest for a while is a very sound strategy.